Illness	Number of cases
Intracranial injury (S06.0)	267
Diarrhoea and gastroenteritis of presumed infectious origin (A09.0)	71
Neonatal jaundice from other and unspecified causes - Neonatal jaundice unspecified (P59.9)	62
Acute upper respiratory infections of multiple and unspecified sites (J06.8)	57
Intestinal malabsorption - Celiac disease (K90.0)	41
Adverse effects not elsewhere classified (T78.0)	41
Crohn disease regional enteritis (K50.0)	35
Ulcerative colitis (K51.0)	34
Bacterial pneumonia not elsewhere classified - Pneumonia due to Mycoplasma pneumoniae (J15.7)	31
Acute obstructive laryngitis croup and epiglottitis - Acute obstructive laryngitis croup (J05.0)	28

Top 10 treatments

Treatment	Number
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	265
(8-98g.10)	165
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	146
(9-985.0)	128
(8-01a)	122
Others therapeutic procedures to influence the immune system (8-547.0)	122
Taking a tissue sample (biopsy) of the upper digestive tract, biliary tract or the pancreas by endoscopy (1-440.9)	112
Measurement of the brain waves - EEG (1-207.1)	107
Administration of medicines to sedate and eliminate pain (8-903)	100
(1-999.3)	98

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 1000

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Diabetes mellitus Typ 2

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ06
CQ27
CQ31

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
160	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
131	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
101	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies